¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"posterior corneal dystrophy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • posterior atlanto-occipital membrane
    µÚ°í¸®µÚÅë¼ö¸·
  • posterior atlantooccipital membrane ³ª membra na atlantooccipitalis p.
    µÚȯÃßÈĵθ·, ÈÄȯÃßÈĵθ·(ý­ü»õÐý­Ô騝).
  • posterior atlantooccipital membrane ³ª membra na atlantooccipitalis p.
    µÚȯÃßÈĵθ·, ÈÄȯÃßÈĵθ·(ý­ü»õÐý­Ô騝).
  • posterior auricular artery
    ÈÄÀ̰³µ¿¸Æ
  • posterior auricular artery ³ª arteria auricularis p.
    µÚ±Ó¹ÙÄûµ¿¸Æ, ÈÄÀ̰³µ¿¸Æ(ý­ì¼Ë¿ÔÑØæ).
  • posterior auricular artery ³ª arteria auricularis p.
    µÚõ¤aÄûµ¿¸Æ, ÈÄÀ̰³µ¿¸Æ(ý­ì¼Ë¿ÔÑØæ).
  • posterior auricular branch
    µÚ±Ó¹ÙÄûµ¿¸Æ
  • posterior auricular groove
    µÚ±Ó¹ÙÄû°í¶û
  • posterior auricular ligament
    µÚ±Ó¹ÙÄûÀδë
  • posterior auricular ligament ³ª ligamentum auricu lare posterius
    µÚ±Ó¹ÙÄûÀδë, ÈÄÀ̰³Àδë(¡­ìåÓá).
  • posterior auricular ligament ³ª ligamentum auricu lare posterius
    µÚõ¤aÄûÀδë, ÈÄÀ̰³Àδë(¡­ìåÓá).
  • posterior auricular nerve
    µÚ±Ó¹ÙÄû½Å°æ
  • posterior auricular nerve of facial nerve
    ¾ó±¼½Å°æÀÇ µÚ±Ó¹ÙÄû½Å°æ, ¾È¸é ½Å°æ(äÔØüãêÌè)ÀÇ ÈÄÀ̰³½Å°æ.
  • posterior auricular nerve of facial nerve
    ¾ó°óº·wÀÇ µÚõ¤aÄû½Å°æ, ¾È¸é ½Å°æ(äÔØüãêÌè)ÀÇ ÈÄÀ̰³½Å°æ. µÚ
  • posterior auricular nerve ³ª nervus auricularis p.
    µÚ±Ó¹ÙÄû½Å°æ, ÈÄÀ̰³½Å°æ(¡­ãêÌè).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • corneal scraping
    °¢¸·Âû°úÇ¥º»(äÃë)
  • corneal sensitivity
    °¢¸·Áö°¢
  • corneal staphyloma
    °¢¸·Æ÷µµÁ¾
  • corneal stroma
    °¢¸·°£Áú, °¢¸·ÁöÁú
  • corneal subepithelial keratosis
    °¢¸·»óÇÇÇϰ¢È­Áõ(¡­ß¾ù«ù»ÊÇûùñø).
  • corneal sulcus
    °¢¸·°í¶û, °¢¸·±¸
  • corneal swelling
    °¢¸·ºÎÁ¾
  • corneal topography
    °¢¸·ÇüŰ˻ç(¹ý)
  • corneal transplant
    °¢¸·À̽Ä, °¢¸·ÀÌ½ÄÆí
  • corneal transplantation
    °¢¸·À̽Ä(¼ú)(¡­ì¹ãÖâú).
  • corneal trephination=trpanation
    °¢¸·¿øÇüÀýÁ¦(¼ú)
  • corneal ulcer
    °¢¸·±Ë¾ç(¡­Ï÷åË).
  • corneal vertex
    °¢¸·¸¶·ç
  • fatty corneal degeneration
    Áö¹æ°¢¸·º¯¼º
  • hyaline corneal degeneration
    À¯¸®Áú°¢¸·º¯¼º, È÷¾Ë¸°°¢¸·º¯¼º
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Posterior process of septal nasal cartilage
    µÚµ¹±â
    [¿¾ ¿ë¾î] Èĵ¹±â
  • Posterior dorsal nucleus
    µÚµîÂÊÇÙ
    [¿¾ ¿ë¾î] ÈĹèÃøÇÙ
  • Posterior parietal arteries
    µÚ¸¶·ç¿±µ¿¸Æ
    [¿¾ ¿ë¾î] ÈĵÎÁ¤µ¿¸Æ
  • Posterior trapezoid nucleus
    µÚ¸¶¸§¼¶À¯Ã¼ÇÙ
    [¿¾ ¿ë¾î] ÈÄ´ÉÇüüÇÙ
  • Posterior cecal artery
    µÚ¸·Ã¢ÀÚµ¿¸Æ
    [¿¾ ¿ë¾î] ÈĸÍÀ嵿¸Æ
  • Posterior mallear fold
    µÚ¸ÁÄ¡ÁÖ¸§
    [¿¾ ¿ë¾î] ÈÄÃß°ñÁÖ¸§
  • Posterior cranial fossa
    µÚ¸Ó¸®»À¿ì¹¬
    [¿¾ ¿ë¾î] Èĵΰ³¿Í
  • Posterior surface
    µÚ¸é
    [¿¾ ¿ë¾î] Èĸé
  • Posterior incudal ligament
    µÚ¸ð·çÀδë
    [¿¾ ¿ë¾î] ÈÄħ°ñÀδë
  • Posterior margin
    µÚ¸ð¼­¸®
    [¿¾ ¿ë¾î] ÈÄ¿¬
  • Posterior cervical intertransverse m.
    µÚ¸ñ°¡·Îµ¹±â»çÀ̱Ù
    [¿¾ ¿ë¾î] °æÈÄȾµ¹±â°£±Ù
  • Scalenus posterior m.
    µÚ¸ñ°¥ºñ±Ù
    [¿¾ ¿ë¾î] ÈĻ簢±Ù
  • Posterior articular surface for talus
    µÚ¸ñ¸»°üÀý¸é
    [¿¾ ¿ë¾î] ÈİŰñ°üÀý¸é
  • Posterior talofibular ligament
    µÚ¸ñ¸»Á¾¾Æ¸®Àδë
    [¿¾ ¿ë¾î] ÈİźñÀδë
  • Posterior triangle of neck
    µÚ¸ñ»ï°¢
    [¿¾ ¿ë¾î] Èİæ»ï°¢
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
PD Doctor of Pharmacy; Dublin Pharmacopoeia; interpupillary distance; Paget disease; pancreatic duct; p...
PICA percutaneous transluminal coronary angioplasty; Porch Index of Communicative Abilities; posterior in...
PP diphosphate group; emphysema [pink puffers]; near point of accommodation [Lat. punctum proximum]; pa...
PPA palpation, percussion, auscultation; pepsin A; phenylpropanolamine; phenylpyruvic acid; Pittsburgh p...
Sp the most posterior point on the posterior contour of the sella turcica; species; specific; specimen;...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
FCMD Fukuyama congenital muscular dystrophy
FCMD Fukuyama type congenital muscular dystrophy
GAD Gracile axonal dystrophy
INAD Infantile neuroaxonal dystrophy
LGMD Limb girdle muscular dystrophy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • nervi cutaneus antebrachii posterior
    ÈÄÀü¿ÏÇÇ ½Å°æ
    ¿ä°ñ ½Å°æ. Àü¿Ï¹èÃøÀÇ ÇǺο¡ ºÐÆ÷ÇÑ´Ù. ÀÏ¹Ý °¨°¢¼º ½Å°æÀÌ´Ù.
  • nervus auricularis posterior
    ÈÄ À̰³ ½Å°æ, µÚ ±Ó¹ÙÄû ½Å°æ
  • nervus cutaneus antebrachii posterior
    µÚ ¾Æ·¡ ÆÈ ÇǺΠ½Å°æ, ÈÄ Àü¿Ï ÇǺΠ½Å°æ
  • nervus cutaneus brachii posterior
    µÚ À§ ÆÈ ÇǺΠ½Å°æ, ÈÄ »ó¿Ï ÇǺΠ½Å°æ
  • nervus cutaneus femoris posterior
    µÚ ´ëÅð ÇǺΠ½Å°æ, ÈÄ ´ëÅð ÇǺΠ½Å°æ
  • nervus ethmoidalis posterior
    µÚ »ç°ñ ½Å°æ, ÈÄ»ç°ñ ½Å°æ
    µ¿ÀǾî=
  • nervus palatinus posterior
    Èı¸°³ ½Å°æ
  • nevi palatinus anterior medius et posterior
    ¾Õ Áß°£ µÚ ±¸°³ ½Å°æ, ÀüÁßÈÄ ±¸°³ ½Å°æ
  • nonworking posterior contact
    ºñÀÛ¾÷Ãø ÈĹæ Á¢ÃË
  • norvus aurscularis posterior
    µÚ ±Ó¹ÙÄû ½Å°æ, ÈÄÀ̰³ ½Å°æ
  • occipital branch of posterior auricular artery
    µÚ ±Ó¹ÙÄû µ¿¸ÆÀÇ ÈĵÎ
  • occipital branches of posterior cerebral artery
    µÚ ´ë³ú µ¿¸ÆÀÇ ÈĵΠ°¡Áö
  • paries posterior orbitae
    ¾È¿Í »óº®
    ÁÖ·Î ÀüµÎ°ñÀÇ ¾È¿ÍÆÇ°ú Á¢Çü°ñ ¼ÒÀÍÀÇ ¾È¿Í¸éÀ¸·Î ±¸¼ºµÈ´Ù.
  • paries posterior ventriculi
    À§ Èĺ®
    ½ÅüÀÇ ÈĹæÀ¸·Î ÇâÇÏ¿© ÀÖ´Â À§º®.
  • pars posterior commissurae anterioris cerebri
    Àü±³·Ã ÈĺÎ
    Àü±³·ÃÀÇ ÀϺημ­ Á¿ìÀÇ ÁßÃøµÎ ȸ, ÇÏÃøµÎ ȸ, ÇØ¸¶¹æ ȸ ¹× ÆíµµÃ¼¸¦ ¿¬¶ôÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
myotonic dystrophy <neurology> An inherited human neuromuscular disease classed as an autosomal dominant disease in which there is progressive muscle weakening and wasting.
A triplet repeat syndromes (like fragile X syndrome), this most common adult form of muscular dystrophy is caused by expansion of the unstable trinucleotide repeat CTG in the 3' untranslated region on chromosome 19q13 (cAMP-dependent muscle protein kinase gene).
Anticipation has been associated with further expansion of the repeat upon transmission to subsequent generations (the inheritance pattern is autosomal dominant), although contraction has been noted to occur as well. Especially severe neonatal cases have been born to affected mothers preferentially, suggesting a role for genomic imprinting as well.
The classic physical signs include atrophy of facial muscles, cataracts, and delayed muscle relaxation. Detection of the expanded trinucleotide repeat is accomplished by PCR or Southern blot and expansion appears to correlate with decreased transcription of the protein kinase gene.
Inheritance: autosomal dominant.
(29 Dec 1997)
craniocarpotarsal dystrophy Congenital association of skeletal defects (ulnar deviation of hands with camptodactyly, talipes equinovarus, and frontal bone defects) and characteristic facies (protrusion of lips as in whistling, sunken eyes with hypertelorism, and small nose); autosomal dominant inheritance.
Synonym: craniocarpotarsal dysplasia, Freeman-Sheldon syndrome, whistling face syndrome.
(05 Mar 2000)
progressive muscular dystrophy A form of progressive muscular atrophy in which the disease begins in the muscle and not in the spinal centres.
Synonym: Erb atrophy, idiopathic muscular atrophy.
(05 Mar 2000)
progressive tapetochoroidal dystrophy An x chromosome-linked abnormality characterised by atrophy of the choroid and degeneration of the retinal pigment epithelium causing night blindness.
(12 Dec 1998)
scapulohumeral muscular dystrophy One of the less well-defined types of muscular dystrophy, probably heterogenous in nature. Onset usually in childhood or early adulthood and both sexes affected. Characterised by weakness and wasting, usually symmetrical, of the pelvic girdle muscles, the shoulder girdle muscles, or both, but not the facial muscles. Muscle pseudohypertrophy, heart involvement, and mental retardation are absent. Variable inheritance.
Synonym: Leyden-Mobius muscular dystrophy, pelvofemoral muscular dystrophy, scapulohumeral muscular dystrophy.
(05 Mar 2000)
pseudohypertrophic muscular dystrophy The most common childhood muscular dystrophy, with onset usually before age 6. Characterised by symmetrical weakness and wasting of first the pelvic and crural muscles and then the pectoral and proximal upper extremity muscles; pseudohypertrophy of some muscles, especially the calf; heart involvement; sometimes mild mental retardation; progressive course and early death, usually in adolescence. X-linked inheritance (affects males and transmitted by females).
Synonym: childhood muscular dystrophy, Duchenne's disease, pseudohypertrophic muscular dystrophy.
(05 Mar 2000)
hypertrophic dystrophy Increase in the number of cells in a squamous epithelium.
Synonym: hypertrophic dystrophy.
(05 Mar 2000)
neuroaxonal dystrophy A rare disorder that begins in the second year of life and is relentlessly progressive; clinically characterised initially by walking difficulties, weakness, and areflexia, later followed by corticospinal and pseudobulbar findings, blindness, loss of pain appreciation, and mental deterioration; pathologically, eosinophilic spheroids of swollen axoplasm are found in various central nuclei; autosomal recessive inheritance.
(05 Mar 2000)
sympathetic reflex dystrophy A syndrome of pain and tenderness, usually to a hand or foot, associated with vasomotor instability, skin changes and rapid development of bony demineralisation (osteoporosis). Frequently will follow a localised trauma, stroke or peripheral nerve injury.
(27 Sep 1997)
syndrome, reflex sympathetic dystrophy A condition that features a group of typical symptoms, including pain (often burning type), tenderness, and swelling of an extremity associated with varying degrees of sweating, warmth and/or coolness, flushing, discoloration, and shiny skin.
(12 Dec 1998)
Duchenne dystrophy The most common childhood muscular dystrophy, with onset usually before age 6. Characterised by symmetrical weakness and wasting of first the pelvic and crural muscles and then the pectoral and proximal upper extremity muscles; pseudohypertrophy of some muscles, especially the calf; heart involvement; sometimes mild mental retardation; progressive course and early death, usually in adolescence. X-linked inheritance (affects males and transmitted by females).
Synonym: childhood muscular dystrophy, Duchenne's disease, pseudohypertrophic muscular dystrophy.
(05 Mar 2000)
Duchenne muscular dystrophy A specific form of muscular dystrophy that is inherited as a sex-linked recessive trait and thus confined to young males and to females with Turner's syndrome. One third of all cases are estimated to be new mutational events.
See: dystrophin.
It is characterised by degeneration and necrosis of skeletal muscle fibres, that are replaced by fat and fibrous tissue.
Symptoms include muscle weakness and in some forms, the appearance of muscle enlargement (pseudo-hypertrophy). Advanced cases can include weakness of the respiratory muscles (compromising breathing) and cardiomyopathy.
Inheritance: sex-linked recessive.
Incidence: 1 in 4000 male births.
(11 Nov 1997)
dystrophy <pathology> Any disorder arising from defective or faulty nutrition, especially the muscular dystrophies.
Origin: L. Dystrophia, Gr. Trephein = to nourish
(18 Nov 1997)
dystrophy, myotonic Inherited disease with myotonia (irritability and prolonged contraction of muscles), mask-like face, premature balding, cataracts, and cardiac disease. Due to a trinucleotide repeat (a stuttering sequence of three bases) in the DNA.
(12 Dec 1998)
infantile neuroaxonal dystrophy <neurology, paediatrics> A rare, familial disorder of early childhood manifested as progressive psychomotor deterioration, increased reflexes, Babinski sign, hypotonia and progressive blindness. Pathologically, eosinophilic spheroids of swollen axoplasm are found in various central nervous system nuclei.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á